State Street Corp Finch Therapeutics Group, Inc. Transaction History

State Street Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.91 - $5.11 $161,805 - $432,893	-84,715 Reduced 77.58%	24,479 $70,000
Q1 2022 May 16, 2022	BUY	$5.02 - $10.47 $14,934 - $31,148	2,975 Added 2.8%	109,194 $549,000
Q4 2021 Feb 14, 2022	BUY	$8.95 - $16.88 $16,172 - $30,502	1,807 Added 1.73%	106,219 $1.06 Million
Q3 2021 Nov 15, 2021	BUY	$12.2 - $16.75 $407,406 - $559,349	33,394 Added 47.02%	104,412 $1.36 Million
Q2 2021 Aug 16, 2021	BUY	$12.03 - $17.51 $854,346 - $1.24 Million	71,018 New	71,018 $999,000

Ticker FNCH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,688,400
Market Cap $575M
Description
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.